Understanding brain extracellular matrix in the tumor microenvironment
了解肿瘤微环境中的脑细胞外基质
基本信息
- 批准号:10938468
- 负责人:
- 金额:$ 24.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-29 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAutomobile DrivingBiologicalBiologyBrainBrain NeoplasmsBrain PathologyCellsClinicalComplexComputational TechniqueData SetDevelopmentDrug toxicityEpilepsyEvaluationExtracellular MatrixGliomaGrowthHistological TechniquesHumanInterneuronsInvadedLinkMachine LearningMedicalMolecularMolecular StructureMorbidity - disease rateNeurologicNeurologic SymptomsNeuronal DysfunctionNeuronsOrganismPathogenesisPatientsPharmaceutical PreparationsProliferatingQuality of lifeRNARecording of previous eventsRecurrenceRefractoryRegulationResearchResourcesRisk FactorsRoleSeizuresSpecimenStromal NeoplasmStructureSynapsesSystemTechnologyTestingTranscriptTumor Promotiondigitaldisabilityepileptiformexperienceinhibitormultidimensional dataneuronal tumornovelpreservationprotein expressionsingle nucleus RNA-sequencingsuccessful interventiontherapeutic targettreatment strategytumortumor microenvironmenttumor progression
项目摘要
Seizures are a common, severe neurologic symptom of brain tumors with up to 80% of patients experiencing at
least one seizure. Recurrent seizures, termed brain-tumor-related epilepsy (BTRE), develop in half of brain tumor
patients and are often refractory to medical management. Poorly controlled epilepsy is the leading risk-factor for
long-term disability in brain tumor patients and complicates the course of treatment due to drug toxicities, loss of
driving privileges, and decreased quality of life. Further, an emerging body of work investigating neuronal
regulation of glioma growth suggests that epileptiform activity promotes tumor proliferation and invasion.
Successful intervention to stop seizures in patients would profoundly reduce neurologic morbidity and may halt
tumor progression. However, current first-line therapy for BTRE, the drug Leviteracetam, a synaptic release
inhibitor, fails to suppress seizures in half of patients. A fundamental shift in our approach to treatment of BTRE
is greatly needed.
Recent studies on the pathogenesis of tumor-related epilepsy have uncovered novel roles for the brain
tumor microenvironment (TME), including tumor-stromal and tumor-neuron interactions that result in bidirectional,
synergistic efforts to re-sculpt the molecular structure of the TME, resulting in neuronal dysfunction
and a feed-forward loop of loss of inhibition, repeated seizures, and tumor progression. In particular, the
perineuronal net (PNN) has been shown to be degraded by gliomas, resulting in dysregulation of inhibitory
interneurons in the adjacent cortex. The TME is a novel and potentially powerful therapeutic target in BTRE;
however, the molecular and cellular mechanisms connecting tumor microenvironment to clinical seizures in
patients remain undefined.
To better understand seizure onset in patients with brain tumors, this project will perform digital spatial
profiling (DSP), an automated system for multiplexed, spatially-linked RNA transcript and protein expression
quantification, and Visium 10x Single-nuclei RNA sequencing on brain tumor specimens to evaluate PNN
structure and composition in the TME. The project will then apply machine-learning approaches to analyze these
high-dimensional data in order to identify PNN features that relate to a clinical history of seizures. This aim will
test the hypothesis that tumor-related PNN degradation in patients is associated with severe neurologic
symptoms. It will also result in major development of novel histologic and computational techniques for evaluation
of PNN structure and function that can be broadly applied to other, similarly complex biomedical datasets.
Completion of these aims will help the Project Leader and research team to better understand how brain
pathologies affect PNNs in patients, generate new biological resources and technologies for the study of human
PNNs, and provide evidence to support preserving or restoring the PNN as a novel, more effective strategy for
treatment of BTRE.
癫痫发作是脑肿瘤常见的严重神经系统症状,高达80%的患者有癫痫发作
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jennifer Hong其他文献
Jennifer Hong的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jennifer Hong', 18)}}的其他基金
Whole-animal, high-resolution imaging of AAV tropism for the nervous system
AAV 神经系统趋向性的全动物高分辨率成像
- 批准号:
10573694 - 财政年份:2022
- 资助金额:
$ 24.46万 - 项目类别:
相似海外基金
Establishment of a method for evaluating automobile driving ability focusing on frontal lobe functions and its application to accident prediction
以额叶功能为中心的汽车驾驶能力评价方法的建立及其在事故预测中的应用
- 批准号:
20K07947 - 财政年份:2020
- 资助金额:
$ 24.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Evaluation of the Effectiveness of Multi-Professional Collaborative Assessment of Cognitive Function and Automobile Driving Skills and Comprehensive Support
认知功能与汽车驾驶技能多专业协同评估效果评价及综合支持
- 批准号:
17K19824 - 财政年份:2017
- 资助金额:
$ 24.46万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Development of Flexible Automobile Driving Interface for Disabled People
残疾人灵活汽车驾驶界面开发
- 批准号:
25330237 - 财政年份:2013
- 资助金额:
$ 24.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Automobile driving among older people with dementia: the effect of an intervention using a support manual for family caregivers
患有痴呆症的老年人的汽车驾驶:使用家庭护理人员支持手册进行干预的效果
- 批准号:
23591741 - 财政年份:2011
- 资助金额:
$ 24.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




